The US Food and Drug Administration has approved the first new drug for the treatment of amyotrophic lateral sclerosis, or ALS, in more than two decades. The FDA announced Friday that Radicava, also known as edaravone, has been approved for use in the United States. The only other drug specifically for the treatment of ALS is riluzole, which was approved for use in the United States in 1995. Tests conducted in Japan found that ALS sufferers who received edaravone experienced a smaller decline in their level of daily functioning compared to those who received a placebo. MT Pharma, the maker of edaravone, said the drug slowed the decline of physical function by 33%. Read more http://www.cnn.com/2017/05/06/health/new-als-drug/
